Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · Real-Time Price · USD
33.29
-0.79 (-2.32%)
At close: Nov 20, 2026, 4:00 PM EST
33.31
+0.02 (0.06%)
After-hours: Nov 20, 2026, 7:30 PM EST
Phibro Animal Health Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 1,541 | 1,518 | 1,296 | 1,018 | 977.89 | 942.26 | |
Revenue Growth | 10.10% | 17.12% | 27.37% | 4.07% | 3.78% | 13.07% |
Cost of Revenue | 1,027 | 1,012 | 886.79 | 704.07 | 679.65 | 656.55 |
Gross Profit | 513.61 | 505.97 | 409.42 | 313.61 | 298.24 | 285.72 |
Selling, General & Admin | 315.47 | 309.33 | 268.15 | 250.92 | 223.35 | 183.53 |
Research & Development | - | - | - | - | - | 20.83 |
Amortization of Goodwill & Intangibles | 2.4 | 2.4 | 2.38 | 2.99 | 3.05 | 2.98 |
Operating Expenses | 317.87 | 311.73 | 270.53 | 253.91 | 226.39 | 207.34 |
Operating Income | 195.74 | 194.24 | 138.89 | 59.71 | 71.85 | 78.38 |
Interest Expense | -46.12 | -46.42 | -35.26 | -23.01 | -18.68 | -12.69 |
Interest & Investment Income | 2.46 | 1.99 | 2.62 | 4.47 | 3.36 | 0.82 |
Currency Exchange Gain (Loss) | -9.26 | -12.62 | -7.87 | -23.86 | -2.46 | 5.22 |
EBT Excluding Unusual Items | 142.82 | 137.19 | 98.38 | 17.31 | 54.07 | 71.72 |
Merger & Restructuring Charges | -11.21 | -11.91 | -25.98 | -7.29 | - | -0.6 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 1.2 |
Asset Writedown | - | - | -5.33 | - | - | - |
Other Unusual Items | 8.48 | 8.5 | -1.96 | - | - | - |
Pretax Income | 139.86 | 137.35 | 67.99 | 10.92 | 54.07 | 72.33 |
Income Tax Expense | 37.14 | 37.63 | 19.73 | 8.5 | 21.47 | 23.15 |
Net Income | 102.71 | 99.72 | 48.26 | 2.42 | 32.61 | 49.18 |
Net Income to Common | 102.71 | 99.72 | 48.26 | 2.42 | 32.61 | 49.18 |
Net Income Growth | 51.46% | 106.61% | 1897.68% | -92.59% | -33.69% | -9.58% |
Shares Outstanding (Basic) | 41 | 41 | 41 | 41 | 41 | 41 |
Shares Outstanding (Diluted) | 41 | 41 | 41 | 41 | 41 | 41 |
Shares Change | 0.57% | 0.70% | 0.38% | 0.05% | - | - |
EPS (Basic) | 2.53 | 2.46 | 1.19 | 0.06 | 0.81 | 1.21 |
EPS (Diluted) | 2.50 | 2.43 | 1.19 | 0.06 | 0.81 | 1.21 |
EPS Growth | 49.65% | 104.20% | 1895.04% | -92.59% | -33.47% | -9.70% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 21.67 | 9.87 | 41.83 | 46.36 | -38.48 | -5.4 |
Free Cash Flow Per Share | 0.53 | 0.24 | 1.03 | 1.14 | -0.95 | -0.13 |
Dividend Per Share | 0.480 | 0.480 | 0.480 | 0.480 | 0.480 | 0.480 |
Dividend Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Gross Margin | 33.33% | 33.33% | 31.59% | 30.82% | 30.50% | 30.32% |
Operating Margin | 12.70% | 12.80% | 10.71% | 5.87% | 7.35% | 8.32% |
Profit Margin | 6.67% | 6.57% | 3.72% | 0.24% | 3.33% | 5.22% |
Free Cash Flow Margin | 1.41% | 0.65% | 3.23% | 4.55% | -3.94% | -0.57% |
EBITDA | 246.48 | 244.23 | 183.08 | 94.45 | 104.4 | 110.04 |
EBITDA Margin | 16.00% | 16.09% | 14.12% | 9.28% | 10.68% | 11.68% |
D&A For EBITDA | 50.74 | 49.99 | 44.18 | 34.74 | 32.56 | 31.66 |
EBIT | 195.74 | 194.24 | 138.89 | 59.71 | 71.85 | 78.38 |
EBIT Margin | 12.70% | 12.80% | 10.71% | 5.87% | 7.35% | 8.32% |
Effective Tax Rate | 26.56% | 27.40% | 29.02% | 77.87% | 39.70% | 32.01% |